Drobek Ales, Bernaleau Léa, Delacrétaz Maeva, Calderon Copete Sandra, Royer-Chardon Claire, Longepierre Mélissa, Monguió-Tortajada Marta, Korzeniowski Jakub, Rotman Samuel, Marquis Julien, Rebsamen Manuele
Department of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Lausanne Genomic Technologies Facility (LGTF), University of Lausanne, Lausanne, Switzerland.
Nat Commun. 2025 Jan 24;16(1):967. doi: 10.1038/s41467-024-55692-y.
Endosomal nucleic acid sensing by Toll-like receptors (TLRs) is central to antimicrobial immunity and several autoimmune conditions such as systemic lupus erythematosus (SLE). The innate immune adaptor TASL mediates, via the interaction with SLC15A4, the activation of IRF5 downstream of human TLR7, TLR8 and TLR9, but the pathophysiological functions of this axis remain unexplored. Here we show that SLC15A4 deficiency results in a selective block of TLR7/9-induced IRF5 activation, while loss of TASL leads to a strong but incomplete impairment, which depends on the cell type and TLR engaged. This residual IRF5 activity is ascribed to a previously uncharacterized paralogue, Gm6377, named here TASL2. Double knockout of TASL and TASL2 (TASL) phenocopies SLC15A4-deficient feeble mice showing comparable impairment of innate and humoral responses. Consequently, TASL mice fail to control chronic LCMV infection, while being protected in a pristane-induced SLE disease model. Our study thus demonstrates the critical pathophysiological role of SLC15A4 and TASL/TASL2 for TLR7/9-driven inflammatory responses, further supporting the therapeutic potential of targeting this complex in SLE and related diseases.
Toll样受体(TLR)介导的内体核酸传感对于抗菌免疫以及几种自身免疫性疾病(如系统性红斑狼疮,SLE)至关重要。先天性免疫衔接蛋白TASL通过与SLC15A4相互作用,介导人TLR7、TLR8和TLR9下游的IRF5激活,但该轴的病理生理功能仍未得到探索。在这里,我们表明SLC15A4缺陷导致TLR7/9诱导的IRF5激活选择性受阻,而TASL缺失导致强烈但不完全的损伤,这取决于细胞类型和所涉及的TLR。这种残余的IRF5活性归因于一种以前未被鉴定的旁系同源物Gm6377,在这里命名为TASL2。TASL和TASL2的双敲除(TASL)模拟了SLC15A4缺陷的虚弱小鼠,显示出先天和体液反应的类似损伤。因此,TASL小鼠无法控制慢性淋巴细胞性脉络丛脑膜炎病毒(LCMV)感染,而在 pristane诱导的SLE疾病模型中受到保护。我们的研究因此证明了SLC15A4和TASL/TASL2在TLR7/9驱动的炎症反应中的关键病理生理作用,进一步支持了在SLE和相关疾病中靶向该复合物的治疗潜力。